Deterioration of liver function and aging disturb sequential systemic therapy for unresectable hepatocellular carcinoma

This study aimed to investigate the clinical characteristics of patients with unresectable hepatocellular carcinoma (HCC), who were eligible for sequential systemic therapy. We evaluated 365 patients with HCC who underwent systemic therapy after 2017. The overall survival (OS) was 13.7 months, 19.2 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimose, Shigeo, Hiraoka, Atsushi, Tanaka, Masatoshi, Iwamoto, Hideki, Tanaka, Takaaki, Noguchi, Kazunori, Aino, Hajime, Yamaguchi, Taizo, Itano, Satoshi, Suga, Hideya, Niizeki, Takashi, Moriyama, Etsuko, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Okamura, Shusuke, Nakano, Masahito, Kawaguchi, Takumi, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554046/
https://www.ncbi.nlm.nih.gov/pubmed/36220865
http://dx.doi.org/10.1038/s41598-022-21528-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554046/
https://www.ncbi.nlm.nih.gov/pubmed/36220865
http://dx.doi.org/10.1038/s41598-022-21528-2

Ejemplares similares